newli
synthes
secretori
membran
protein
must
attain
nativ
conform
spontan
assist
erresid
cytosol
chaperon
export
er
er
qualiti
control
mechan
assur
function
incompet
misfold
unassembl
oligomer
protein
retain
target
proteolysi
via
erassoci
degrad
erad
pathway
hurtley
helniu
brodski
mccracken
bonifacino
weismann
ellgaard
et
al
wickner
et
al
erad
involv
recognit
disloc
proteolysi
misfold
polypeptid
proteasom
multicatalyt
enzym
complex
local
cytoplasm
nucleu
baumeist
et
al
bonifacino
weismann
brodski
mccracken
plemper
wolf
atpdepend
cleavag
process
facilit
multipl
ubiquitin
attach
group
lysin
residu
substrat
catalyz
cascad
enzymat
reaction
involv
ubiquitinactiv
conjug
enzym
addit
ubiquitinprotein
ligas
hershko
ciechanov
traffick
defect
recogn
underli
mechan
grow
number
genet
diseas
includ
cystic
fibrosi
cf
diabet
insipidu
antitrypsin
defici
thoma
et
al
bonifacino
weismann
hershko
ciechanov
aridor
balch
kopito
schwartz
ciechanov
cf
preval
recess
genet
disord
caucasian
popul
caus
dysfunct
cf
transmembran
conduct
regul
cftr
member
atpbind
cassett
transport
protein
famili
riordan
et
al
rommen
et
al
cftr
campstimul
channel
resid
predominantli
cell
surfac
less
abundantli
endosom
compart
bradburi
channel
consist
two
homolog
halv
compris
six
transmembran
helic
nucleotid
bind
domain
connect
regulatori
domain
riordan
et
al
complex
multidomain
structur
conceiv
render
posttransl
fold
wildtyp
wt
cftr
ineffici
approxim
newli
synthes
wt
cftr
trap
er
coreglycosyl
fold
intermedi
appar
molecular
weight
degrad
min
erad
proteasom
activ
respons
least
part
degrad
co
posttransl
ubiquitin
incomplet
fold
cftr
er
jensen
et
al
ward
et
al
xiong
et
al
howev
inhibit
proteasom
fail
promot
process
coreglycosyl
wt
well
cftr
jensen
et
al
ward
et
al
newli
synthes
cftr
enter
secretori
pathway
atpdepend
conform
matur
lukac
et
al
zhang
et
al
assist
cytosol
erresid
chaperon
yang
et
al
pind
et
al
loo
et
al
meacham
et
al
process
high
mannos
type
nlink
glycan
complex
type
oligosaccharid
cismedi
golgi
region
reflect
decreas
electrophoret
mobil
kd
provid
conveni
method
monitor
traffick
cftr
cheng
et
al
lukac
et
al
ward
kopito
riordan
fold
complexglycosyl
cftr
slow
turnov
vivo
h
also
display
conform
resist
proteolysi
vitro
zhang
et
al
posttransl
fold
conform
matur
cftr
independ
er
golgi
vesicular
transport
impli
complex
glycosyl
prerequisit
attain
nativ
conform
lukac
et
al
ward
kopito
zhang
et
al
major
cfassoci
point
mutat
includ
common
cftr
impair
biosynthet
process
disrupt
posttransl
fold
er
welsh
smith
zielenski
tsui
riordan
recent
identifi
mechanist
distinct
categori
mutat
caus
prematur
termin
frameshift
mutat
cf
gene
haardt
et
al
although
er
process
coohtermin
truncat
cftr
variant
miss
last
amino
acid
residu
cftr
similar
wt
form
biolog
halflif
complexglycosyl
mutant
sixfold
shorter
wt
counterpart
haardt
et
al
although
proteolyt
elimin
mechan
process
mutant
entrap
er
extens
studi
welsh
smith
kopito
riordan
cellular
process
respons
short
resid
time
truncat
cftr
postgolgi
compart
remain
obscur
show
delet
cooh
terminu
render
complexglycosyl
truncat
cftr
highli
suscept
proteasomedepend
proteolysi
postgolgi
compart
includ
plasma
membran
structur
destabil
demonstr
increas
proteas
suscept
vitro
diminish
thermost
complexglycosyl
mutant
vivo
may
serv
signal
prematur
proteolysi
contrast
lysosom
proteolysi
appear
repres
ratelimit
step
degrad
complexglycosyl
wt
cftr
result
reveal
novel
aspect
proteasomedepend
degrad
pathway
elimin
nonn
cftr
escap
er
qualiti
control
influenza
hemagglutinin
ha
epitop
attach
terminu
ubiquitin
use
pcr
mutagenesi
cdna
yeast
ubiquitin
templat
provid
dr
r
haguenauertsapi
jacqu
monod
univers
pari
vii
pari
franc
gener
chimera
extracellular
transmembran
segment
interleukin
receptor
tac
fuse
cytoplasm
tail
construct
sequenc
verifi
error
introduc
cdna
encod
tac
provid
dr
j
bonifacino
nation
institut
health
bethesda
md
tac
stabli
transfect
cell
use
pnut
express
cassett
haardt
et
al
mixtur
stabli
transfect
cell
express
wt
truncat
cftr
miss
last
amino
acid
residu
cftr
respect
tac
gener
maintain
describ
haardt
et
al
intestin
epithelia
express
endogen
cftr
cultur
describ
lukac
et
al
lukac
et
al
cell
transient
transfect
lipofectamin
haardt
et
al
cell
wash
icecold
pb
lyse
ripa
buffer
mm
nacl
mm
trishcl
triton
sd
sodium
deoxychol
ph
contain
leupeptin
pepstatin
mm
iodoacetamid
mm
pmsf
nuclei
unbroken
cell
remov
centrifug
g
min
protein
denatur
laemmli
sampl
buffer
separ
sdspage
transfer
nitrocellulos
membran
immunoblot
perform
describ
previous
use
mous
monoclon
anticftr
antibodi
ab
kartner
et
al
mous
monoclon
antiha
covanc
antiubiquitin
ab
santa
cruz
biotechnolog
inc
lukac
et
al
primari
ab
visual
horseradish
sheep
igg
enhanc
chemiluminesc
ecl
western
blot
kit
amersham
pharmacia
biotech
bhk
cell
puls
label
presenc
methionin
cystein
mciml
amersham
pharmacia
biotech
chase
complet
medium
specifi
time
cftr
immunoprecipit
mixtur
anticftr
ab
describ
lukac
et
al
durat
puls
chase
period
withdraw
sampl
indic
schemat
figur
radioact
associ
cftr
visual
fluorographi
quantifi
phosphorimag
pdi
use
imagequ
softwar
haardt
et
al
determin
express
level
wt
truncat
cftr
cell
surfac
earli
endosom
bhk
cell
metabol
label
steadi
state
overnight
rins
h
buffer
mm
nacl
mm
hepe
mm
kcl
mm
mm
mm
glucos
ph
cell
biotinyl
presenc
mgml
biotinamido
ezlink
sulfonhsssbiotin
pierc
chemic
co
h
buffer
lukac
et
al
cell
wash
icecold
pb
supplement
bsa
mm
mm
solubil
ripa
buffer
biotinyl
cftr
isol
immunoprecipit
anticftr
ab
streptavidinsepharos
sigmaaldrich
biotinyl
cftr
visual
fluorographi
radioact
measur
phosphorimag
analysi
cell
wash
icecold
pb
three
time
resuspend
homogen
medium
sucros
mm
hepe
mm
edta
mm
dtt
ph
supplement
leupeptin
pepstatin
mm
pmsf
cell
homogen
nitrogen
cavit
describ
zhang
et
al
wherea
bhk
cell
homogen
dounc
homogen
sediment
unbroken
cell
nuclei
g
min
mitochondria
pellet
centrifug
g
min
postnuclear
supernat
microsom
fraction
selfform
percol
densiti
gradient
percol
sucros
mm
hepe
mm
edta
leupeptin
pepstatin
ph
g
min
densiti
profil
gradient
verifi
densitymark
bead
sigmaaldrich
fraction
download
describ
lukac
et
al
experi
lysosom
label
fluidphas
marker
fluoresceindextran
mgml
kd
molecular
probe
overnight
chase
full
medium
h
alkalin
phosphatas
mannosidas
ii
activ
specif
marker
plasma
membran
lysosom
golgi
region
respect
measur
describ
lukac
et
al
lukac
et
al
fluoresc
associ
fraction
determin
fluoresc
spectrophotometri
presenc
triton
bhk
cell
express
wt
cftr
incub
presenc
cycloheximid
ensur
degrad
coreglycosyl
wt
cftr
lukac
et
al
isol
er
golgi
plasma
microsom
perform
describ
zhang
et
al
microsom
mgml
digest
hse
medium
mm
hepe
sucros
ph
presenc
indic
concentr
trypsin
proteinas
k
min
zhang
et
al
proteolysi
termin
addit
mm
pmsf
sampl
immedi
denatur
laemmli
sampl
buffer
min
probe
immunoblot
analysi
plasma
membran
campdepend
halid
conduct
bhk
cell
express
cftr
determin
iodid
efflux
describ
moham
et
al
iodid
efflux
initi
replac
load
buffer
efflux
medium
compos
mm
nitrat
place
iodid
extracellular
medium
replac
everi
minut
efflux
buffer
ml
steadi
state
reach
intracellular
camp
level
rais
agonist
forskolin
mm
ctpcamp
mm
isobutylmethyl
xanthan
achiev
maxim
phosphoryl
cftr
collect
efflux
medium
resum
addit
min
amount
iodid
sampl
determin
iodideselect
electrod
orion
demonstr
previous
steadi
state
express
level
complexglycosyl
cftr
miss
last
amino
acid
design
cftr
decreas
compar
wt
cftr
heterolog
express
system
haardt
et
al
contrast
delet
last
amino
acid
residu
cftr
without
effect
mickl
et
al
haardt
et
al
also
shown
neither
translat
rate
biosynthet
matur
cftr
significantli
impair
er
transient
haardt
et
al
stabl
bhk
express
system
benharouga
gl
lukac
unpublish
data
propos
contrast
preval
cfassoci
process
mutat
eg
cftr
compromis
biogenesi
cftr
destabil
matur
form
distal
stage
biosynthet
endocyt
pathway
account
phenotyp
manifest
truncat
cftr
haardt
et
al
examin
whether
impair
plasma
membran
target
complexglycosyl
truncat
cftr
attribut
acceler
degrad
efficaci
cell
surfac
deliveri
mutant
determin
first
bhk
cell
constitut
express
wt
truncat
cftr
metabol
label
methionin
cystein
overnight
cell
cftr
coval
tag
sulfonhsssbiotin
solubil
immunoprecipit
cftr
biotinyl
polypeptid
isol
streptavidinsepharos
visual
fluorographi
separ
sdspage
fig
phosphorimag
analysi
reveal
abund
biotinyl
cftr
rel
wt
cftr
mixtur
clone
fig
b
steadi
state
level
complexglycosyl
cftr
pool
also
diminish
rel
wt
cftr
determin
quantit
western
blot
use
anticftr
ab
fig
fig
c
complex
coreglycosyl
form
wt
truncat
cftr
could
distinguish
distinct
electrophoret
mobil
well
endoglycosidas
h
sensit
describ
previous
shown
fig
fig
cheng
et
al
parallel
decreas
size
complexglycosyl
biotinyl
pool
truncat
cftr
suggest
plasma
membran
target
larg
preserv
confirm
notion
cell
surfac
deliveri
newli
synthes
cftr
measur
wt
cftr
puls
label
min
molecul
arriv
cell
surfac
biotinyl
chase
biotinyl
cftr
affin
isol
visual
fluorographi
fig
e
biot
radioact
biotinyl
form
quantifi
phosphorimag
analysi
express
percentag
respect
pulselabel
coreglycosyl
cftr
fig
e
lysat
cell
surfac
target
effici
cftr
mean
sem
n
wt
cftr
sinc
measur
compound
rapid
degrad
complexglycosyl
cftr
h
see
also
fig
b
haardt
et
al
calcul
target
effici
cftr
repres
underestim
suggest
plasma
membran
deliveri
complexglycosyl
cftr
larg
preserv
light
effici
clathrindepend
intern
cftr
princ
et
al
princ
et
al
lukac
et
al
bradburi
proteolysi
plasma
membraneresid
atpbind
cassett
transport
vacuolarlysosom
compart
loayza
micha
hick
katzmann
et
al
hypothes
coohtermin
truncat
may
interfer
recycl
cftr
lead
prematur
endolysosom
proteolysi
test
hypothesi
dispos
rate
metabol
label
complexglycosyl
cftr
measur
presenc
lysosom
proteas
inhibitor
allow
convers
core
complexglycosyl
form
fig
degrad
rate
unalt
upon
expos
cell
chloroquin
bafilomycin
b
agent
inhibit
endolysosom
proteolysi
dissip
acid
lumin
ph
interf
cargo
deliveri
fig
b
similarli
leupeptin
pepstatin
inhibitor
cathepsin
b
h
l
n
seglen
neglig
effect
degrad
rate
fig
fig
b
steadi
state
express
truncat
cftr
fig
c
contrast
drug
stabil
interleukin
receptor
chain
tac
target
lysosom
degrad
fig
hemar
et
al
valid
efficaci
suggest
initi
proteolysi
truncat
cftr
larg
independ
endolysosom
proteas
analysi
reveal
dispos
complexglycosyl
wt
cftr
mitig
chloroquin
fig
fig
f
examin
discord
role
lysosom
proteas
wt
cftr
degrad
subcellular
fraction
perform
enrich
shortliv
proteolyt
intermedi
may
difficult
detect
treat
cell
cathepsin
inhibitor
heavi
light
microsom
contain
predominantli
lysosom
golgi
complex
plasma
membran
endosom
respect
isol
percol
densiti
gradient
fig
although
cathepsin
inhibitor
stabil
complexglycosyl
wt
cftr
lysosom
well
lightdens
fraction
modest
accumul
cftr
could
document
immunoblot
analysi
fig
b
similar
result
obtain
lysosom
isol
calciumprecipit
method
data
shown
kawashima
et
al
surprisingli
leupeptin
pepstatin
provok
accumul
degrad
intermedi
wt
cftr
predominantli
lysosom
fig
b
inhibitor
also
provok
appear
breakdown
product
isol
lysosom
intestin
epithelia
express
cftr
endogen
impli
lysosom
proteolysi
attribut
heterolog
overexpess
data
shown
consid
cathepsin
inhibitor
unabl
promot
er
process
coreglycosyl
form
lukac
et
al
ward
kopito
result
suggest
endolysosom
proteas
essenti
elimin
complexglycosyl
fulllength
wt
cftr
addit
endolysosom
proteas
appear
involv
process
proteolyt
intermedi
deriv
wt
cftr
proteasom
respons
degrad
misfold
polypeptid
recogn
er
qualiti
control
shortliv
cytosol
plasma
membran
protein
ligandinduc
intern
hochstrass
bonifacino
weismann
hershko
ciechanov
brodski
mccracken
plemper
wolf
schwartz
ciechanov
reveal
involv
proteasom
metabol
truncat
cftr
impact
peptid
aldehyd
mg
cbzleuleuleucin
lactacystin
specif
irrevers
inhibitor
subunit
assess
fenteani
et
al
disappear
complexglycosyl
coreglycosyl
cftr
inhibit
respect
lactacystin
drug
present
puls
label
chase
fig
fig
b
fig
exert
less
pronounc
effect
fig
b
compar
inhibit
observ
lactacystin
ad
puls
label
fig
c
chase
fig
latter
protocol
ensur
augment
convers
core
complexglycosyl
form
attribut
lactacystin
effect
similarli
prevent
er
golgi
complex
transport
residu
coreglycosyl
cftr
brefeldin
bfa
fail
influenc
inhibitori
effect
lactacystin
fig
substanti
notion
dispos
complexglycosyl
mutant
delay
rather
escap
coreglycosyl
form
facilit
lactacystin
fact
neither
lactacystin
mg
promot
process
coreglycosyl
cftr
fig
similarli
cftr
mutat
identifi
jensen
et
al
van
oen
et
al
matur
effici
cftr
n
neglig
increas
presenc
lactacystin
n
delet
cooh
terminu
destabil
cftr
exclus
postgolgi
compart
retent
fold
cftr
er
would
protect
degrad
take
advantag
fact
bfa
provok
accumul
fold
cftr
er
without
interf
erad
stabil
fold
cftr
measur
elimin
immatur
coreglycosyl
form
fig
e
turnov
fold
coreglycosyl
cftr
fourfold
slower
h
complexglycosyl
cftr
h
fig
f
contrast
er
retent
margin
increas
halflif
wt
cftr
h
vs
h
fig
g
underlin
previou
observ
destabil
cftr
primarili
manifest
distal
stage
secretori
pathway
similar
stabil
observ
upon
retain
complexglycosyl
cftr
distal
golgi
region
aluminum
fluorid
benharouga
gl
lukac
unpublish
observ
rule
cross
talk
lysosom
proteasom
degrad
pathway
account
stabil
complexglycosyl
cftr
specif
drug
examin
bhk
cell
express
chimera
although
former
polypeptid
substrat
erad
bonifacino
et
al
latter
target
lysosom
proteolysi
mark
et
al
anticip
proteasom
inhibitor
mitig
disappear
wherea
bafilomycin
b
proteasom
inhibitor
stabil
fig
fig
c
consist
notion
proteasom
activ
account
least
part
proteolysi
complexglycosyl
truncat
cftr
proteasom
inhibitor
increas
steadi
state
level
complexglycosyl
cftr
two
fourfold
accord
densitometr
analysi
immunoblot
fig
also
reflect
elev
campactiv
anion
conduct
plasma
membran
fig
e
lactacystin
treatment
significantli
increas
protein
kinas
iodid
releas
bhk
cell
constitut
express
cftr
compar
nontreat
cell
fig
e
investig
influenc
proteasom
inhibitor
resid
time
truncat
cftr
cell
surfac
turnov
biotinyl
cftr
measur
techniqu
halflif
biotinyl
cftr
sevenfold
shorter
h
wt
cftr
h
fig
fig
b
lactacystin
inhibit
turnov
biotinyl
cftr
respect
observ
provid
direct
support
hypothesi
proteasom
directli
indirectli
involv
proteolysi
complexglycosyl
cftr
cell
surfac
endosom
compart
fig
fig
sinc
recognit
substrat
destin
destruct
proteasom
requir
polyubiquitin
modif
hershko
ciechanov
laney
hochstrass
plemper
wolf
hirsh
ploegh
examin
whether
cftr
subject
ubiquitin
attach
cell
transient
cotransfect
plasmid
encod
wt
cftr
hatag
ubiquitin
haub
haub
detect
monoclon
antiha
ab
immunoprecipit
cftr
abund
high
molecular
weight
immunoreact
polypeptid
augment
lactacystin
suggest
proteasom
activ
involv
degrad
polyubiquitin
cftr
fig
top
lane
similar
result
obtain
monitor
conjug
endogen
ub
monoclon
antiub
ab
fig
middl
lane
ubiquitin
cftr
could
detect
cell
express
cftr
haub
individu
fig
top
lane
mock
transfect
fig
lane
valid
specif
assay
discrimin
whether
polyubiquitin
cftr
deriv
core
andor
complexglycosyl
cftr
jensen
et
al
ward
et
al
xiong
et
al
doubl
immunoprecipit
metabol
label
cftr
perform
stabli
transfect
bhk
cell
puls
label
min
chase
h
ensur
elimin
coreglycosyl
cftr
verifi
fluorographi
fig
b
bottom
lane
see
also
fig
second
set
sampl
separ
ubiquitin
adduct
achiev
sequenti
immunoprecipit
anticftr
antiub
ab
result
show
neglig
amount
polyubiquitin
coreglycosyl
cftr
persist
initi
chase
fig
b
top
bottom
lane
contrast
radioact
appear
high
molecular
weight
polyubiquitin
cftr
present
last
h
chase
fig
b
top
lane
accumul
polyubiquitin
cftr
pronounc
cell
transient
coexpress
cftr
haub
fig
c
like
due
higher
immunoprecipit
effici
antiha
ab
ubiquitin
conjug
detect
upon
inhibit
lysosom
proteolysi
mock
transfect
cell
fig
b
top
middl
c
consid
turnov
complexglycosyl
coreglycosyl
cftr
sensit
proteasom
inhibitor
coreglycosyl
form
larg
elimin
proteasom
inhibit
conclud
least
fraction
polyubiquitin
cftr
origin
complexglycosyl
cftr
although
rule
small
amount
polyubiquitin
cftr
deriv
coreglycosyl
form
follow
observ
substanti
notion
complexglycosyl
cftr
form
ubiquitin
adduct
ubiquitin
complexglycosyl
form
visual
antiub
ab
separ
core
complexglycosyl
form
immunoprecipit
anticftr
ab
wheat
germ
agglutinin
affin
chromatographi
data
shown
furthermor
coexpress
domin
neg
cftr
delay
dispos
complexglycosyl
mutant
cftr
data
shown
nonn
partial
denatur
solubl
protein
subject
ubiquitin
andor
proteasomemedi
degrad
pacifici
et
al
sadi
et
al
michalek
et
al
gilon
et
al
laney
hochstrass
similar
scenario
may
prevail
cftr
coohtermin
tail
engag
structur
stabil
cftr
poster
compart
larg
bodi
evid
demonstr
exist
intra
intermolecular
interact
cftr
seibert
et
al
ostedgaard
et
al
ostedgaard
et
al
hall
et
al
nevil
et
al
zhang
et
al
naren
et
al
lu
pedersen
compar
conform
stabil
complexglycosyl
wt
cftr
situ
proteas
suscept
vivo
thermost
assay
perform
conform
cytosol
domain
probe
limit
proteolyt
digest
conjunct
immunoblot
method
implement
reveal
conform
differ
wt
cftr
zhang
et
al
intact
microsom
isol
differenti
centrifug
bhk
cell
enrich
complexglycosyl
wt
cftr
cyclohexamid
chase
subject
limit
proteolysi
presenc
increas
concentr
trypsin
immunoblot
analysi
proteolyt
fragment
anticftr
ab
recogn
demonstr
distinct
proteolyt
digest
pattern
moder
reproduc
increas
proteas
sensit
complexglycosyl
cftr
compar
wt
cftr
fig
similar
result
obtain
proteinas
k
use
anticftr
ab
data
shown
indic
also
conform
alter
upon
truncat
cooh
terminu
complexglycosyl
cftr
conform
unstabl
anticip
polypeptid
vivo
thermost
would
compromis
temperatur
depend
turnov
complexglycosyl
wt
cftr
compar
metabol
studi
turnov
complexglycosyl
cftr
fivefold
faster
h
h
fig
fig
c
sharp
contrast
turnov
wt
cftr
margin
affect
vs
h
fig
fig
simplest
interpret
data
intrins
structur
instabl
cftr
becom
appar
elev
temperatur
lead
thermodenatur
proteolysi
wherea
compact
tertiari
structur
wt
cftr
resist
unfold
combin
transcript
cotransl
posttransl
mechan
contribut
er
qualiti
control
prevent
misfold
secretori
membran
protein
travers
secretori
pathway
ellgaard
et
al
wickner
et
al
mori
nevertheless
sever
exampl
demonstr
fidel
er
qualiti
control
far
perfect
nonfunct
polypeptid
escap
er
retent
wherea
mutant
partial
fulli
preserv
biolog
function
trap
caus
sever
human
diseas
cf
alpha
inhibitor
defici
thoma
et
al
zielenski
tsui
aridor
balch
schwartz
ciechanov
nonn
polypeptid
could
also
gener
poster
compart
result
unfold
upon
environment
stress
mutat
compromis
nativ
form
stabil
goldenberg
pacifici
et
al
parsel
lindquist
sitt
et
al
littl
known
mechan
respons
degrad
abnorm
membran
protein
poster
compart
mammalian
cell
aggreg
furin
incomplet
assembl
golgi
coronaviru
mutant
destin
lysosom
degrad
golgi
region
without
reach
cell
surfac
armstrong
et
al
wolin
et
al
vanslyk
et
al
poster
qualiti
control
mechan
appear
respons
target
vacuolar
degrad
mutant
plasma
membran
atpas
late
golgi
proteas
model
protein
compris
secretori
invertas
terminu
lambda
repressor
saccharomyc
cerevisia
wilcox
et
al
chang
fink
hong
et
al
aggreg
unoccupi
class
ii
major
histocompat
complex
molecul
crosslink
cell
surfac
membran
protein
transferrin
receptor
evok
preferenti
lysosom
target
degrad
weissman
et
al
amigorena
et
al
although
exampl
illustr
nonn
membran
protein
target
lysosom
proteolysi
either
arriv
cell
surfac
intern
complexglycosyl
truncat
cftr
distinct
intracellular
fate
present
compel
evid
indic
dramat
decreas
express
level
resid
time
complexglycosyl
truncat
cftr
attribut
missort
lysosom
degrad
transgolgi
endosom
compart
instead
truncat
cftr
target
plasma
membran
compar
effici
wt
counterpart
fig
turnov
total
cell
surfac
biotinyl
cftr
pool
insensit
inhibitor
endolysosom
proteas
contrast
weak
base
cathepsin
inhibitor
stabil
fulllength
form
degrad
intermedi
wt
cftr
transfect
cell
well
epithelia
highlight
multipl
role
endolysosom
proteolysi
turnov
wt
cftr
fig
fig
sever
criteria
use
establish
proteasom
involv
acceler
metabol
truncat
cftr
postgolgi
compart
includ
cell
surfac
first
degrad
rate
complexglycosyl
cftr
delay
presenc
lactacystin
specif
inhibitor
proteasom
fenteani
et
al
fig
second
dramat
extens
plasma
membran
resid
time
biotinyl
cftr
evok
lactacystin
fig
impli
proteasom
indispens
proteolysi
truncat
cftr
cell
surfac
andor
endosom
compart
sinc
proteasom
inhibitor
impact
degrad
indirect
effect
lactacystin
lysosom
proteolysi
could
preclud
fig
third
lactacystin
evok
accumul
polyubiqutin
adduct
complexglycosyl
cftr
consist
notion
fraction
cftr
tag
polyubiquitin
chain
degrad
fig
final
lactacystin
partial
restor
express
level
complexglycosyl
cftr
well
plasma
membran
campactiv
chlorid
conduct
cftr
transfect
without
facilit
biogenesi
mutant
fig
fig
e
although
observ
indic
proteasom
activ
one
ratelimit
step
turnov
fulllength
complexglycosyl
cftr
proteasom
inhibitor
fail
restor
mutant
stabil
wt
cftr
could
explain
incomplet
inhibit
proteasom
activ
andor
involv
present
unidentifi
proteolyt
mechan
coohtermin
tail
cftr
might
confer
stabil
matur
cftr
sever
mechan
combin
thereof
delet
cooh
terminu
compris
postsynapt
disclarg
zonula
motif
ensur
associ
cftr
phosphoprotein
vitro
vivo
may
facilit
lysosom
degrad
compromis
endosom
sort
recycl
hall
et
al
short
et
al
moyer
et
al
similar
paradigm
propos
acceler
degrad
receptor
upon
prevent
bind
cao
et
al
howev
possibl
appear
unlik
sinc
steadi
state
express
level
turnov
rate
cftr
variant
lack
coohtermin
amino
acid
residu
normal
mickl
et
al
haardt
et
al
neither
aggreg
cftr
transgolgi
earli
endosom
target
mutant
lysosom
degrad
final
absenc
coohtermin
tail
may
structur
destabil
fold
cftr
increas
portion
nonn
molecul
suscept
proteolysi
evid
suggest
nonn
state
solubl
polypeptid
induc
mutat
thermal
chemic
denatur
lead
acceler
degrad
parsel
lindquist
hershko
ciechanov
brodski
mccracken
plemper
wolf
paradigm
may
appli
degrad
nonn
plasma
membran
protein
includ
truncat
cftr
well
base
enhanc
proteas
suscept
decreas
vivo
thermost
cftr
fig
fig
specul
structur
destabil
nativ
form
induc
disrupt
interact
cooh
terminu
use
variou
yeast
screen
assay
sitedirect
mutagenesi
proteolyt
motif
transcript
factor
establish
ubiquitinconjug
enzym
recogn
hydrophob
stretch
expos
hydrophob
surfac
amphipath
helic
sadi
et
al
gilon
et
al
johnson
et
al
similar
motif
normal
buri
insid
globular
domain
cftr
insert
membran
plane
may
serv
recognit
signal
support
notion
decreas
plasma
membran
resid
time
impair
express
level
receptor
also
attribut
structur
destabil
gether
et
al
wilson
limbird
howev
mechan
respons
downregul
g
receptor
could
partial
rescu
ligand
stabil
remain
obscur
key
question
remain
resolv
whether
ubiquitin
prerequisit
proteasomedepend
degrad
mutant
cftr
cell
surfac
endosom
compart
sever
tyrosin
kinas
g
receptor
observ
undergo
ligandinduc
ubiquitin
downregul
via
lysosom
andor
proteasom
degrad
bonifacino
weismann
hershko
ciechanov
hick
strou
gover
ubiquitin
also
appear
necessari
suffici
induc
intern
downregul
plasma
membran
receptor
transport
eg
via
vacuolar
proteolysi
yeast
hick
constitut
downregul
epitheli
sodium
channel
enac
associ
ubiquitinligas
propos
follow
similar
degrad
rout
contrast
unassembl
subunit
channel
degrad
proteasomedepend
mechan
er
staub
et
al
sinc
coval
noncoval
attach
ubiquitin
serv
degrad
signal
plasma
membran
protein
via
intern
gover
et
al
shih
et
al
one
possibl
scenario
augment
ubiquitin
cftr
associ
protein
facilit
intern
mutant
hand
light
multipl
tyrosin
dileucinebas
endocyt
signal
cftr
ubiquitin
attach
may
prerequisit
endocytosi
lukac
et
al
princ
et
al
hu
et
al
consist
dispens
natur
ubiquitin
downregul
mutant
receptor
proceed
without
endocytosi
presum
direct
associ
proteasom
andor
present
unidentifi
proteas
jocker
et
al
wilson
limbird
recognit
proteasom
subunit
abl
degrad
nonn
polypeptid
lack
polyubiquitin
conjug
support
notion
ubiquitinindepend
degrad
mechan
rule
murakami
braun
et
al
sheaff
et
al
strickland
et
al
importantli
degrad
pathway
mutual
exclus
may
function
parallel
sinc
retrograd
transloc
cftr
via
translocon
unlik
occur
postgolgi
compart
xiong
et
al
coordin
action
multipl
proteolyt
system
invok
resolv
topolog
problem
dispos
transmembran
segment
exofaci
loop
cftr
degrad
appear
initi
unfold
cytosol
domain
proteasomedepend
manner
biochem
well
function
rescu
cell
surfac
resid
wt
cftr
data
shown
proteasom
inhibitor
substanti
hypothesi
wherea
initi
cleavag
matur
wt
cftr
oppos
mutant
reli
activ
lysosm
proteas
subsequ
degrad
wt
cftr
converg
endolysosom
demonstr
overlap
proteolyt
fragment
pattern
presenc
cathepsin
inhibitor
fig
b
although
truncat
cftr
one
first
mutant
plasma
membran
protein
subject
sequenti
proteasom
lysosom
breakdown
coordin
action
proteolyt
system
without
preced
although
lysosom
proteasom
involv
constitut
ligandinduc
dispos
renal
napi
cotransport
pdgf
receptor
respect
mori
et
al
la
et
al
pfister
et
al
recognit
mechan
substrat
proteasom
remain
unknown
consid
delet
coohtermin
tail
appear
destabil
cftr
structur
propos
ubiquitinproteasom
pathway
may
play
role
recognit
elimin
cftr
also
nonn
partial
unfold
plasma
membran
protein
